Access

Letter

Nature 442, 307-311 (20 July 2006) | doi:10.1038/nature04837; Received 13 January 2006; Accepted 27 April 2006; Published online 28 May 2006

The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3

Paul A. C. Cloos1,4, Jesper Christensen1,4, Karl Agger1,4, Alessio Maiolica2, Juri Rappsilber2, Torben Antal1, Klaus H. Hansen1 & Kristian Helin1,3

  1. Biotech Research & Innovation Centre, Fruebjergvej 3, 2100 Copenhagen, Denmark
  2. FIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milan, Italy
  3. Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark
  4. *These authors contributed equally to this work

Correspondence to: Kristian Helin1,3 Correspondence and requests for materials should be addressed to K.H. (Email: kristian.helin@bric.dk).

Top

Methylation of lysine and arginine residues on histone tails affects chromatin structure and gene transcription1, 2, 3. Tri- and dimethylation of lysine 9 on histone H3 (H3K9me3/me2) is required for the binding of the repressive protein HP1 and is associated with heterochromatin formation and transcriptional repression in a variety of species4, 5, 6. H3K9me3 has long been regarded as a 'permanent' epigenetic mark7, 8. In a search for proteins and complexes interacting with H3K9me3, we identified the protein GASC1 (gene amplified in squamous cell carcinoma 1)9, which belongs to the JMJD2 (jumonji domain containing 2) subfamily of the jumonji family, and is also known as JMJD2C10. Here we show that three members of this subfamily of proteins demethylate H3K9me3/me2 in vitro through a hydroxylation reaction requiring iron and alpha-ketoglutarate as cofactors. Furthermore, we demonstrate that ectopic expression of GASC1 or other JMJD2 members markedly decreases H3K9me3/me2 levels, increases H3K9me1 levels, delocalizes HP1 and reduces heterochromatin in vivo. Previously, GASC1 was found to be amplified in several cell lines derived from oesophageal squamous carcinomas9, 11, 12, and in agreement with a contribution of GASC1 to tumour development, inhibition of GASC1 expression decreases cell proliferation. Thus, in addition to identifying GASC1 as a histone trimethyl demethylase, we suggest a model for how this enzyme might be involved in cancer development, and propose it as a target for anti-cancer therapy.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

The expanding world of histone lysine demethylases

Nature Structural & Molecular Biology News and Views (01 Apr 2007)

Research Highlights

Nature Chemical Biology News and Views (01 Dec 2007)

See all 6 matches for News And Views